Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
2014329 citationsJoselyn Rojas, Mervin Chávez-Castillo et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Valmore Bermúdez
Since
Specialization
Citations
This map shows the geographic impact of Valmore Bermúdez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valmore Bermúdez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valmore Bermúdez more than expected).
Fields of papers citing papers by Valmore Bermúdez
This network shows the impact of papers produced by Valmore Bermúdez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valmore Bermúdez. The network helps show where Valmore Bermúdez may publish in the future.
Co-authorship network of co-authors of Valmore Bermúdez
This figure shows the co-authorship network connecting the top 25 collaborators of Valmore Bermúdez.
A scholar is included among the top collaborators of Valmore Bermúdez based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Valmore Bermúdez. Valmore Bermúdez is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bermúdez, Valmore, et al.. (2019). A score function as quality measure for cardiac image enhancement techniques assessment. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas).3 indexed citations
9.
Chacín, Maricarmen, et al.. (2019). Evaluación de la neuropatía periférica y el riesgo de ulceración en pacientes diabéticos según los criterios del Grupo Internacional de trabajo sobre pie diabético. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas).1 indexed citations
10.
Áñez, Roberto, et al.. (2017). Prevalencia de la diabetes mellitus tipo 2 y sus factores de riesgo en individuos adultos de la ciudad de Cuenca- Ecuador. 6(1). 10–21.25 indexed citations
11.
Bermúdez, Valmore, et al.. (2015). Osteoporosis en mujer de 30 años con insuficiencia ovárica precoz. A propósito de un caso. Redalyc (Universidad Autónoma del Estado de México). 34(2). 31–35.1 indexed citations
Rojas, Joselyn, et al.. (2013). Acantosis Nigricans en una paciente con diabetes tipo 1: reporte de un caso. Redalyc (Universidad Autónoma del Estado de México). 32(3). 41–44.1 indexed citations
15.
Calvo, Maria Clara Costa, et al.. (2013). Prevalencia de sobrepeso y obesidad en escolares de la parroquia Coquivacoa del municipio Maracaibo - Venezuela. 8(3). 68–76.2 indexed citations
16.
Arráiz, Nailet, et al.. (2009). Dislipidemias primarias como factor de riesgo para la enfermedad coronaria. Redalyc (Universidad Autónoma del Estado de México). 4(1). 18–25.2 indexed citations
17.
Bermúdez, Valmore, et al.. (2008). Pharmacologic Treatment of Obesity: Pitfalls and New Promises. Redalyc (Universidad Autónoma del Estado de México).1 indexed citations
18.
Bermúdez, Valmore, Edward Rojas, Aída Souki, et al.. (2008). Niveles inusualmente elevados de Lipoproteína(a) en poblaciones Afro-Americanas del sur del Lago de Maracaibo. Redalyc (Universidad Autónoma del Estado de México).1 indexed citations
19.
Bermúdez, Valmore, et al.. (2007). Tratamiento farmacológico de la obesidad: presente, pasado y futuro. 26(1). 10–20.3 indexed citations
20.
Bermúdez, Valmore, et al.. (2006). Oat derived-glucan significantly improves HDLc and diminishes LDLc and Non-HDL cholesterol in overweigh individuals with mild hypercholesterolemia. Redalyc (Universidad Autónoma del Estado de México). 1(3). 28–34.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.